Halaman 3 - Leukemia Dokter Terbaik - TOP-82 dokter

Terdaftar sebagai salah satu dokter terbaik di Israel versi Forbes, Dr. Gal Goldstein memimpin Departemen Onkologi dan Hemato-Onkologi Anak di Hadassah Medical Center.

• Lebih dari 20 tahun spesialisasi dalam hemato-onkologi anak
• Ahli dalam transplantasi sumsum tulang haploidentik
• Fokus pada retinoblastoma dan pengobatan presisi
• Anggota dari empat asosiasi onkologi anak internasional
• Menempuh pendidikan di Universitas Tel Aviv

Dr. Eckhart Weidmann mengepalai sektor Hematologi di Klinik Nordwest, spesialis dalam perawatan kelainan darah dengan pengalaman praktik lebih dari 30 tahun.

• Salah satu dokter terbaik untuk limfoma non-Hodgkin
• Profesor dengan keahlian akademik dan klinis yang luas
• Berfokus pada kelainan darah yang kompleks

Dr. Alemdar berspesialisasi dalam pengobatan Leukemia, membawa pengalaman akademik dan rumah sakit yang luas ke praktiknya di Kompleks Rumah Sakit Medical Park Antalya.

• Sertifikasi dewan dalam Onkologi Medis dari Universitas Akdeniz
• Pengalaman bertahun-tahun di rumah sakit universitas terkemuka termasuk Rumah Sakit Universitas Akdeniz
• Pelatihan komprehensif di Kedokteran Internal sebelum berspesialisasi dalam Onkologi

Profesor Zila Zuckerman adalah spesialis hematologi dan transplantologi yang berdedikasi di Rambam Medical Center.

• Ahli dalam kanker darah dewasa dan anak-anak
• Fokus pada transplantasi sumsum tulang untuk leukemia
• Bagian dari tim pusat medis akademik utama

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Memimpin Departemen Hematologi di Pusat Medis Hadassah, spesialis dalam perawatan lanjutan untuk kanker darah.

• Profesor dengan pengalaman lebih dari tiga dekade dalam penyakit darah ganas
• Menjalani pelatihan selama tiga tahun di Memorial Sloan-Kettering Cancer Center di New York
• Ahli dalam transplantasi sumsum tulang dan terapi gen baru
• Wanita pertama yang menjabat sebagai Dekan Fakultas Kedokteran Hadassah
• Menerima penghargaan Healing with the Heart atas perawatan pasien yang luar biasa

Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang dan diakui oleh Forbes sebagai salah satu dokter terbaik.

• Spesialisasi dalam mengobati anak-anak dengan leukemia dan kanker darah langka
• 20 tahun praktik berdedikasi dalam hematologi pediatrik
• Pasien dan orang tua memanggilnya dokter yang 'mentransplantasikan kehidupan'

Dr. Spielberg adalah seorang onkohematolog yang berspesialisasi dalam kanker darah di Pusat Medis Assuta.

• Keahlian difokuskan khusus pada leukemia dan kelainan darah lainnya
• Berbasis di rumah sakit swasta terkemuka di Israel, Pusat Medis Assuta
• Memberikan perawatan kanker terintegrasi dengan akses ke diagnostik tingkat lanjut

Prof. Bosch memimpin penelitian global dalam Leukemia Limfositik Kronis (LLC), dengan lebih dari 80 uji klinis aktif yang mengembangkan pengobatan baru.

• Spesialisasi dalam LLC dan gangguan limfoproliferatif sejak tahun 2000
• Presiden kelompok studi LLC Spanyol (GELLC)
• Menerbitkan lebih dari 100 artikel di jurnal terkemuka seperti NEJM dan Nature Medicine
• Fellowship di Institute of Cancer Genetics, Universitas Columbia

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Dr. Serdar Bedii Omay telah mempublikasikan 65+ artikel ilmiah tentang hematologi dan transplantasi sumsum tulang, dengan pengalaman luas dari Universitas Hacettepe dan Ege.

• Spesialisasi dalam hematologi di Mie Medical School Jepang
• Profesor Hematologi di Universitas Teknik Karadeniz
• Lebih dari 30 tahun pengalaman dalam hematologi
• Menulis 112 makalah pertemuan dan 34 presentasi konferensi

Dr. Apak telah memimpin Divisi Hematologi-Onkologi Anak di Universitas Istanbul-Cerrahpaşa selama lebih dari 20 tahun, dengan spesialisasi dalam kemoterapi leukemia dan transplantasi sumsum tulang.

• Pengalaman lebih dari 30 tahun di bidang hematologi dan onkologi anak
• Keahlian dalam terapi sel CAR-T untuk kasus leukemia yang resisten
• Menerbitkan 75 makalah internasional tentang onkologi anak
• Kepala bagian pediatri saat ini di Universitas Istanbul